Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative Colitis: a Randomized Controlled Trial

NCT07718529 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT07718529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07718529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative Colitis: a Randomized Controlled Trial
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
January 31, 2031
Enrollment
224 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis in remission